BD (NYSE:BDX) today announced the introduction of the Elyra thulium fiber laser (TFL) system for treating kidney stones.

In early May 2026, Becton, Dickinson and Company reported higher quarterly sales of US$4.71 billion but swung to a net loss, raised its full-year adjusted earnings guidance, completed the divestiture ...

The Elyra TFL system is available in two versions, Elyra and Elyra Plus.

After parting ways with its diabetes franchise nearly three years ago, BD is slimming down even further with a plan to divest its diagnostic and biosciences businesses as the company nears the finish ...

BD (NYSE:BDX) has introduced the Elyra Thulium Fiber Laser System for kidney stone treatment, aiming to improve efficiency and flexibility in urologic procedures. The company also restated a long term ...

BD has become the subject of a lawsuit from Tela Bio, with the rival maker of surgical mesh implants saying the major medtech wielded its sector dominance to push competing products out of the hernia ...

The scientific-instrument company Waters will deepen its biological sciences footprint by merging with the biosciences and diagnostic solution business of Becton, Dickinson (BD). The companies value ...

Dubai, United Arab Emirates – The Dubai branch of BD (Becton, Dickinson, and Company) (NYSE: BDX), a leading global medical technology company, is marking its presence at the region’s key healthcare ...